Abstract
Dr. Shore is Associate Director for Clinical Research, National Institute of Mental Health, Bethesda, Maryland. Address reprint requests to Dr. Shore, Room 8235, MSC 9669, 6001 Executive Blvd., Bethesda, MD 20892. Key Words: Research Training Research Funding Commentaries Today's psychiatric residents have chosen a specialty that is profoundly different from the psychiatry of only a decade ago. The Human Genome Project and burgeoning genetic technologies will permit us finally to discover genes that produce vulnerability to mental disorders. A panoply of non-invasive imaging technologies affords us the opportunity to see the living human brain at work. Basic neuroscience is progressing at an accelerating rate and, indeed, is one of the most exciting frontiers in all of science. With psychiatric perspectives contributing, in turn, to the further development of the aforementioned fields, the discipline is unequivocally a full participant in the general medical research renaissance. On the clinical front, advances in diagnosis, epidemiology, treatment/diagnosis-matching, psychopharmacology, and other areas have led to numerous innovations and insights. A jarring counterpoint to this auspicious picture is the persistent "endangered species" status of the clinicianresearcher in psychiatry. Although not unique to the discipline (witness the recent National Academy of Sciences report,If you're having problem loading pages
Try our single-page mode to load one page at a time


Preview Only. This article cannot be rented because we do not currently have permission from the publisher.
Preview Only
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy